Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosylated lysosomal membrane protein (GLMP) is a highly glycosylated, single-pass transmembrane protein found on the lysosomal membrane where it serves as an essential accessory subunit for the lysosomal dipeptide transporter MFSD1. GLMP protects MFSD1 from lysosomal proteolysis and is required for its proper localization to the lysosome. The MFSD1-GLMP complex functions as a general uniporter for cationic, neutral, and anionic dipeptides, establishing an alternative export pathway for proteolysis products in lysosomes. Deficiency of GLMP (or MFSD1) leads to severe organ dysfunction, highlighting its importance in cellular degradation and metabolite recycling. Although closely related to other lysosomal membrane proteins (such as LAMP family proteins), GLMP is a distinct protein and critical for lysosomal transporter function.
No drugs targeting GLMP explicitly; mechanisms for potential targeting would likely involve modulation of MFSD1-GLMP transporter function or lysosomal stability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosylated lysosomal membrane protein (GLMP).